Explore

Trendline Trendline
Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy

Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy

Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy
Trendline Trendline
Bracco Imaging Introduces BubbleGen Early Access Program for Cell Therapy Innovation

Bracco Imaging Introduces BubbleGen Early Access Program for Cell Therapy Innovation

Bracco Imaging Introduces BubbleGen Early Access Program for Cell Therapy Innovation
Trendline Trendline
Thermo Fisher Scientific Launches New Bioreactor for Scalable Cell Therapy Manufacturing

Thermo Fisher Scientific Launches New Bioreactor for Scalable Cell Therapy Manufacturing

Thermo Fisher Scientific Launches New Bioreactor for Scalable Cell Therapy Manufacturing
Trendline Trendline
Alcami Completes Acquisition of Tjoapack, Expanding CDMO Capabilities

Alcami Completes Acquisition of Tjoapack, Expanding CDMO Capabilities

Alcami Completes Acquisition of Tjoapack, Expanding CDMO Capabilities
Trendline Trendline
UCB to Acquire Candid Therapeutics for $2.2 Billion to Enhance TCE Antibody Portfolio

UCB to Acquire Candid Therapeutics for $2.2 Billion to Enhance TCE Antibody Portfolio

UCB to Acquire Candid Therapeutics for $2.2 Billion to Enhance TCE Antibody Portfolio
Trendline Trendline
Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing

Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing

Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing
Trendline Trendline
FUJIFILM Biosciences and NextCell Launch New Platform for MSC Research

FUJIFILM Biosciences and NextCell Launch New Platform for MSC Research

FUJIFILM Biosciences and NextCell Launch New Platform for MSC Research
Trendline Trendline
Lilly Invests $4.5 Billion in Indiana Manufacturing, Opens Genetic Medicine Facility

Lilly Invests $4.5 Billion in Indiana Manufacturing, Opens Genetic Medicine Facility

Lilly Invests $4.5 Billion in Indiana Manufacturing, Opens Genetic Medicine Facility
Trendline Trendline
4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA

4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA

4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA
Trendline Trendline
SK Capital Partners Sells Noramco and Affiliates to Siegfried Holding AG

SK Capital Partners Sells Noramco and Affiliates to Siegfried Holding AG

SK Capital Partners Sells Noramco and Affiliates to Siegfried Holding AG
Trendline Trendline
UCB Acquires Candid Therapeutics to Enhance Immunology Pipeline

UCB Acquires Candid Therapeutics to Enhance Immunology Pipeline

UCB Acquires Candid Therapeutics to Enhance Immunology Pipeline
Trendline Trendline
Bracco Launches BubbleGen Early Access Program for Cell Therapy Innovation

Bracco Launches BubbleGen Early Access Program for Cell Therapy Innovation

Bracco Launches BubbleGen Early Access Program for Cell Therapy Innovation